Published September 2021 | Version v1
Journal article

A potentially valuable nano graphene oxide/USPIO tumor diagnosis and treatment system

  • 1. School of Pharmaceutical Sciences, Guangxi Medical University, No. 22 Shuangyong Road, Nanning 530021, Guangxi (China)
  • 2. Guangxi Cancer Hospital and Guangxi Medical University Affiliated Cancer Hospital, Department of Experimental Pathology, No. 22 Shuangyong Road, Nanning 530021, Guangxi (China)

Description

Highlights: • An integrated diagnosis and treatment system based on NGO/USPIO was established. • Nano graphene oxide (NGO) for chemo-photothermal anti-tumor therapy. • USPIO for diagnosing the tumor and confirming the carrier at the tumor site. Due to increased requirements for precision cancer treatment, cancer chemotherapy and combination therapies have gradually developed in the direction of diagnosis and treatment integration. In this study, a non-toxic nano carrier that demonstrates integrated MRI signal enhancing performance, as well as better chemotherapy and photothermal conversion performance, was prepared and characterized. Furthermore, the carrier was used to construct an integrated system of tumor diagnosis and treatment. Our in vitro studies showed that this system has a considerable inhibition effect on tumor cells during the treatment of chemotherapy when combined with PTT, and in vivo studies showed that the system could improve the MRI signal of the tumor site with application of a safe dosage. Thus, this system based on NGO/USPIO has the potential to be a multi-functional nano drug delivery system integrating diagnosis and treatment benefits and applications that are worthy of further research.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.msec.2021.112293

Additional details

Identifiers

DOI
10.1016/j.msec.2021.112293;
PII
S092849312100432X;

Publishing Information

Journal Title
Materials Science and Engineering. C, Biomimetic Materials, Sensors and Systems
Journal Volume
128
Journal Page Range
vp.
ISSN
0928-4931

Optional Information

Copyright
Copyright (c) 2021 Elsevier B.V. All rights reserved.